Abstract

Objective: The main objective of the present research was formulation and evaluation of ezetimibe rapidmelts.
 Methods: As ezetimibe comes under Class II drug, solubility of the drug should be increased before formulation. For that solid dispersions were prepared with β-CD and PVP K-30 using coevaporation and kneading method. Among those solid dispersions prepared with β-CD (1:1.5) using coevaporation method has given better drug entrapment values compared to other solid dispersions. Those solid dispersions were formulated as rapidmelts using direct compression. In direct compression method, rapidmelts were prepared using superdisintegrants such as crospovidone, croscarmellose sodium, and starch 1500. Those are evaluated for both pre-compression and post-compression parameters. Rapidmelts of ezetimibe were prepared using sublimation method with subliming agents camphor, urea, and ammonium bicarbonate. The concentrations of subliming agents were found to be 2.5, 5.0, and 7.5%.
 Results: Rapidmelts prepared using direct compression and sublimation methods were evaluated for weight variation, hardness, friability, % drug content, and disintegration time. The best formulation was subjected to stability testing for 6 months at 25°C/60% RH and 40°C/75% RH. All the prepared formulations compiled with the pharmacopeial limits. In all the formulations, results suggest that E12 formulation has given the best results.
 Conclusion: From the result, it was concluded that rapidmelts prepared using sublimation method which has given better result than direct compression method. That final formulation was further evaluated for in vivo studies using rabbits.

Highlights

  • Oral route of administration is one among the foremost convenient route for drug administration

  • As ezetimibe comes under BCS Class II drug, solid dispersions of ezetimibe were prepared using different polymers in several ratios using different techniques to reinforce the solubility of the drug

  • The present study was done on rapidmelts of ezetimibe using direct compression and sublimation methods

Read more

Summary

Introduction

Oral route of administration is one among the foremost convenient route for drug administration. As per USFDA, rapidmelts were defined as “A solid dosage form containing a medicinal substance or active ingredient which disintegrates rapidly when placed upon the tongue within a matter of seconds” [1]. Prescription rapidmelt products initially were developed to beat the problem in swallowing among pediatric and geriatric populations who have difficulty in swallowing conventional tablets and capsules [2]. Solid dispersions are a way that depends on melting or dissolution process to disperse one or more active ingredient during in a carrier or matrix with in the solid state. This ensures increased drug wettability and reduction of particle aggregation and increased drug dissolution [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call